...
机译:恶性神经胶质瘤患者的肿瘤溶解产物和负载IL-18的树突状细胞引起Th1反应,肿瘤特异性CD8 +细胞毒性T细胞
Department of Neurosurgery Brain Research Institute Niigata University;
Department of Neurosurgery Brain Research Institute Niigata University;
Department of Neurosurgery Brain Research Institute Niigata University;
Department of Neurosurgery Brain Research Institute Niigata University;
Department of Neurosurgery Brain Research Institute Niigata University;
Department of Neurosurgery Brain Research Institute Niigata University;
CTL; dendritic cell; IL-18; immunotherapy; malignant glioma; tumor lysate;
机译:恶性神经胶质瘤患者的肿瘤溶解产物和负载IL-18的树突状细胞引起Th1反应,肿瘤特异性CD8 +细胞毒性T细胞。
机译:负载外来体的树突状细胞在神经胶质瘤患者中引起肿瘤特异性CD8 +细胞毒性T细胞。
机译:外来体负载的树突状细胞诱导神经胶质瘤患者的肿瘤特异性CD8 + sup>细胞毒性T细胞
机译:Cdsalpha〜+树突状细胞的增强含有肿瘤萃取物的Cdsalpha〜+树突细胞的免疫应答富含热冲击蛋白在肿瘤轴承小鼠中
机译:使死者复活:树突状细胞交叉呈递来自凋亡细胞的抗原,并诱导病毒和肿瘤特异性的细胞毒性T淋巴细胞。
机译:胶质瘤相关抗原肽肽对恶性胶质瘤患者患者的粘性抗原肽肽的与自体肿瘤裂解的树突式细胞疫苗接种疫苗接种
机译:用肿瘤裂解性树突状细胞疫苗接种引发抗原特异性细胞毒性T细胞,恶性胶质瘤患者